• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    中华临床感染病杂志

    中华临床感染病杂志

    JournalISSN 1674-2397

    年发文量

    研究主题

    论文(1529)

    排序
    1Chinese Guidelines for the Diagnosis and Treatment of Human Immunodeficiency Virus Infection/acquired Immunodeficiency Syndrome (2024 Edition)

    The Acquired Immunodeficiency Syndrome Professional Group of the Society of Infectious Diseases of the Chinese Medical Association formulated the first edition of theChinese Guidelines for the Diagnosis and Treatment of human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) (referred to as the Guidelines) in 2005. The 2024 edition of the Guidelines has been compiled by updating the 2021 fifth edition, incorporating the latest research advancements in antiviral therapy, comprehensive management, opportunistic infections, concurrent tumors, and the prevention and intervention of HIV infection. The new edition also introduces a new section on "Incomplete immune reconstitution", proposes the concept of "HIV vulnerable populations" for the first time with recommendations for their diagnosis and treatment. This edition of the Guidelines covers 14 sections: epidemiology, pathogenic characteristics, laboratory tests, pathogenesis, clinical presentation and staging, diagnostic criteria, common opportunistic infections, antiretroviral therapy, immune reconstitution inflammatory syndrome, incomplete immune reconstitution, AIDS-related neoplasms, prevention of mother-to-child transmission and conception in serodiscordant couples, pre- and post-exposure prophylaxis, and whole-course management of HIV infection. This edition of the Guidelines aims to assist clinical physicians in making informed decisions in the diagnosis, treatment, and management of HIV/AIDS and will be periodically revised and updated based on domestic and international research progress.

    2024引用:5
    引用
    AI阅读
    加入学术空间
    2Liver function injury in patients with omicron variant COVID-19 and its influencing factors
    ,,,

    Objective:To analyze the incidence of liver function injury in patients infected with 2019-nCoV omicron variant and its influencing factors.Methods:The clinical data and laboratory findings of 897 COVID-19 patients infected with omicron variant in Zhejiang province from February 23 to July 14, 2022 were retrospectively analyzed. Patients were divide into liver function injury group ( n=243) and non-liver function injury group ( n=654) based on liver function indicators. The clinical characteristics and laboratory tests were compared between the two groups, and influencing factors of liver function injury were analyzed. SPSS 26.0 statistical software was used for data analysis. Results:The incidence of liver injury in this series was 27.09% (243/897). The median age of patients in liver injury group was older, the body mass index (BMI) was higher( Z=-6.237 and -2.166, both P<0.05), the proportions of patients with hypertension and diabetes, and with severe clinical classification were higher ( χ2=17.087, 27.509 and 12.945, all P<0.01) ; the proportion of vaccinated patients was lower ( χ2=17.766, P<0.01) than those in non-liver injury group. The levels of platelet, hemoglobin, albumin and potassium in liver injury group were lower than those in non-liver injury group ( Z=-4.631, -2.368, -10.593 and -2.141, all P<0.05), while serum ALT, AST, γ-GT, urea nitrogen, glucose and hs-CRP levels were higher than those in the non-liver injury group ( Z=-7.451, -8.663, -4.410, -3.824, -3.278 and -3.884, all P<0.01). Multivariate Logistic regression analysis showed that age ( OR=2.580, 95% CI 1.429-4.657, P=0.002), history of diabetes ( OR=3.650, 95% CI 1.698-7.849, P=0.001), and decreased hemoglobin ( OR=1.993, 95% CI 1.066-3.726, P=0.031) and increased hs-CRP ( OR=1.797, 95% CI 1.283-2.517, P=0.001) were risk factors associated with liver function injury, while vaccination ( OR=0.499, 95% CI 0.312-0.798, P=0.004) was the protective factor for liver function. Conclusion:Liver function injury is frequently observed in COVID-19 patients infected with omicron variant, which is linked to age, underlying disease, and elevated inflammatory markers; while vaccination can lower the risk of liver injury in infected patients.

    2023
    引用
    AI阅读
    加入学术空间
    3Research progress of risk prediction model of multidrug-resistant bacteria infection in ICU patients
    ,

    Multidrug-resistant organism (MDRO) infections not only prolong length of hospital stay and increase medical costs, but also elevate mortality risk of patients. Compared to other wards, patients in intensive care unit (ICU) are more susceptible to MDRO infections and linked to poorer prognosis. Therefore, predicting and preventing MDRO infections among ICU patients are crucial. This article reviews risk factors for MDRO infections and the progress of prediction models among ICU inpatients, aiming to provide references for constructing MDRO risk prediction models with higher reliability and practicality for clinical application.

    2023
    引用
    AI阅读
    加入学术空间
    4Mycobacterium avium pulmonary disease presenting as solitary pulmonary lesion: Report of two cases and literature review
    ,,,

    以孤立的肺结节或肺肿块为表现的非结核分枝杆菌肺病较罕见,临床上极易被误诊,治疗方案尚无统一标准。因临床上易误诊为肺癌,手术切除为常见的治疗方式。本文报道2例表现为孤立性病灶的伴PET/CT中氟代脱氧葡萄糖升高的鸟分枝杆菌肺病,描述其临床和影像学特征、实验室检查、微生物学检查、治疗和预后,并结合文献进行讨论分析,以提高临床认识,并为诊疗分析提供借鉴。

    2023
    引用
    AI阅读
    加入学术空间
    5The bright eyes will never be forgotten
    ,

    本文以平行病历的形式,从医生、患者和家属的不同角度,生动地记录了临床工作中的几个温暖片段,强调了医生和患者之间互信、互助、互爱的重要性,凸显了医患共决策在疾病诊治过程中的重要作用。

    2023
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1529 篇论文

    高被引作者

    作者引用发文
    Lanjuan Li212339
    Jifang Sheng206217
    Hainv Gao197912
    Wei-Feng Liang19619
    Qiang Fang19262
    Yonghong Xiao121918
    Dawei Cui110417
    Yu Chen10736
    Hangping Yao10685
    Shigui Yang10675

    高产作者

    作者引用发文
    Lanjuan Li212339
    Jianrong Huang5129
    YiLin Ma7624
    Hongzhou Lu96318
    Yonghong Xiao121918
    Dawei Cui110417
    Jifang Sheng206217
    Yuming Wang3415
    Zhiliang Gao4415
    Yunsong Yu8614

    相关期刊

    Chinese journal of microbiology and immunology
    Anti-infection Pharmacy
    Journal of Pediatric Pharmacy
    Infectious Disease Information
    Chinese Journal of Viral Diseases
    Chinese Journal of Respiratory and Critical Care Medicine
    Chinese Journal of Infectious Diseases
    Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)
    暨南大学学报(自然科学与医学版)
    热带医学杂志